✦ LIBER ✦

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI

✍ Scribed by O. Pagani; A. O’Neill; M. Castiglione; R.D. Gelber; A. Goldhirsch; C.-M. Rudenstam; J. Lindtner; J. Collins; D. Crivellari; A. Coates; F. Cavalli; B. Thürlimann; E. Simoncini; M. Fey; K. Price; H.-J. Senn

Book ID: 117664120
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 170 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)10036-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of adjuvant endocrine treatme

Comparison of adjuvant endocrine treatment (tamoxifen and goserelin) vs. chemotherapy (CMF) in premenopausal patients with hormone-responsive early breast cancer: Results from the Austrian Breast Cancer Study Group (ABCSG)

✍ E. Kubista; M. Seifert; M. Gnant; R. Jakesz 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 163 KB

0-28. Adjuvant high dose chemotherapy (H

0-28. Adjuvant high dose chemotherapy (HD CT) without bone marrow rescue in breast cancer patients (b.c. pts) with 10 or more positive nodes (N ≥ 10): preliminary results of an Italian breast cancer adjuvant study group (GROCTA) trial

✍ D. Amoroso; F. Boccardo; A. Rubagotti; A. Ballestrero; F. Ferrando; F. Brema; F. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Decreased immunoreactivity for p27 prote

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V

✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m